Skip to main content
Fig. 2 | BMC Chemistry

Fig. 2

From: A dual methodology employing ion-pair chromatography and built-in UV spectrophotometry for quantifying recently approved combination of mometasone and indacaterol in a novel combined metered dose inhaler: assessing the greenness, carbon footprint, blueness, and whiteness

Fig. 2

IPC chromatogram demonstrating the separation of IND and MOM. a IND (7.5 μg/mL, 2.18 min) and MOM (8.0 μg/mL, 3.95 min) in the synthetic mixture, b IND (1.5 μg/mL, 2.24 min) MOM (1.6 μg/mL, 4.03 min) in the inhaled capsule

Back to article page